Drug intelligence / Profile preview

RdCVFL

Development stage
Unknown
Lead developer
SparingVision
Modality
Gene Therapies, Recombinant Proteins and Enzymes
Administration
Intravitreal, Ophthalmic
01

Overview

RdCVFL (rod-derived cone viability factor long form) is an investigational research protein and the long isoform encoded by the nucleoredoxin-like 1 (NXNL1) gene. Unlike the short isoform RdCVF, which acts as a secreted trophic factor promoting glucose uptake, RdCVFL is a thioredoxin-like, redox-active enzyme that protects photoreceptors from oxidative stress and exhibits chaperone and S-denitrosylase activity. It is not developed as a standalone commercial product but is a key component of SPVN06, an AAV-based, mutation-agnostic gene therapy developed by SparingVision. SPVN06 expresses both RdCVF and RdCVFL and is in Phase I/II clinical development for the treatment of retinitis pigmentosa and other rod-cone dystrophies.

Other names
RdCVF-Lrod-derived cone viability factor long formrod-derived cone viability factor long isoformthioredoxin-like protein rod-derived cone viability factor
02

Targets

MAPT (Microtubule-associated protein tau)

Beyond the preview

Go deeper on RdCVFL.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RdCVFL.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call